CPT 11
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What CPT 11 Means in Everyday Medical Language
CPT 11 is another name for the chemotherapy drug irinotecan hydrochloride, which is also sold under the brand name Camptosar. This medicine is mainly used to treat colorectal cancer that has spread to other parts of the body. It works by blocking an enzyme called topoisomerase I, which cancer cells need to copy and repair their DNA. By interfering with this process, CPT 11 causes damage to cancer cells that they cannot fix, leading to their death and helping to slow or stop cancer growth.
Why CPT 11 Can Matter in Cancer Care
Doctors often use CPT 11 when colorectal cancer has returned after earlier treatments or when other chemotherapy drugs, such as fluorouracil, have not been effective enough. It can be given alone or with other medicines to improve treatment results. While it is mainly approved for colorectal cancer, researchers are also studying CPT 11 for other types of cancer. Understanding this drug helps patients and caregivers recognize one option in cancer treatment, though it is not a cure and may not work the same for everyone.
What Patients Might See or Hear About CPT 11
Patients may hear the names CPT 11, Camptosar, or irinotecan hydrochloride during doctor visits, treatment planning, or when reviewing medical reports. These all refer to the same drug. It may be mentioned when discussing chemotherapy options, side effects, or clinical trials. Common side effects can include diarrhea, nausea, and lowered blood counts, but your care team will explain what to expect based on your situation.
Where CPT 11 May Appear in Your Care
You might see CPT 11 listed in your treatment plan, chemotherapy schedule, or medication list. It can also appear in clinical trial information if you are considering research studies. Drug information sheets and educational materials from your healthcare team may use any of its names. If you see these terms, asking your care team how CPT 11 fits into your care can help clarify its role.
Common Confusions and Questions About CPT 11
Because CPT 11 has several names—irinotecan hydrochloride, CPT-11, and Camptosar—it can be confusing. These names all mean the same medicine. It’s important not to assume that seeing this name means a specific treatment is planned or that it will work the same for everyone. Patients often wonder about side effects, how the drug is given, and how it fits with other treatments. Asking your care team about these topics can provide clear, personalized answers.
How to Read CPT 11 in Context
Seeing the term CPT 11 in a medical report or conversation is a signal to ask how this drug relates to your specific care. It is not a diagnosis or a treatment decision by itself. Your healthcare providers can explain whether CPT 11 is part of your treatment plan, what benefits and risks it may have, and how it will be given. Understanding the context helps you feel more informed and prepared.
Safety and Next Steps
This information is meant to help you understand what CPT 11 is and how it might be used in cancer care. It is not a substitute for medical advice tailored to your situation. Your healthcare providers know your health history and can explain whether CPT 11 is appropriate for you. If you have questions or concerns about CPT 11, such as side effects or treatment goals, don’t hesitate to ask your doctor or nurse. Talking openly with your care team is the best way to feel informed and supported as you make decisions about your treatment.
Sources
Public source information used for this glossary entry includes: